Bupropion Tablets and Sustained-Release Tablets and Novoeight
Determining the interaction of Bupropion Tablets and Sustained-Release Tablets and Novoeight and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bupropion
Brand name: Aplenzin, Buproban, Forfivo XL, Wellbutrin SR, Wellbutrin XL, Zyban, Zyban Advantage Pack, Budeprion XL
Synonyms: Bupropion, BuPROPion
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bupropion Tablets and Sustained-Release Tablets-Novoeight recombinant
- Bupropion Tablets and Sustained-Release Tablets-Novolin 70/30
- Bupropion Tablets and Sustained-Release Tablets-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Bupropion Tablets and Sustained-Release Tablets-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Bupropion Tablets and Sustained-Release Tablets-Novolin N
- Bupropion Tablets and Sustained-Release Tablets-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Novoeight-Burapren Injection
- Novoeight-Burn-O-Jel Topical application
- Novoeight-Burnamycin Topical application
- Novoeight-Burosumab
- Novoeight-Burosumab-twza
- Novoeight-Burosumab-twza Subcutaneous